Search

Search Constraints

You searched for: Author/Creator Descourt, Renaud

Search Results

5. First‐line pembrolizumab for non–small cell lung cancer patients with PD‐L1 ≥50% in a multicenter real‐life cohort: The PEMBREIZH study. (5th February 2020)

6. Lorlatinib for advanced anaplastic lymphoma kinase–positive non–small cell lung cancer: Results of the IFCT-1803 LORLATU cohort. (May 2022)

7. Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial. Issue 4 (4th October 2018)

8. Impact of KRAS G12C mutation in patients with advanced non-squamous non-small cell lung cancer treated with first-line pembrolizumab monotherapy. (December 2022)

9. Paclitaxel–bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study. (May 2022)